Finally, experimental data supporting PMP22 expression by selective CNS neurons (including spinal cord and brainstem ones) in human might implicate a direct CNS autoimmune pathway against PMP22 in CMT1A patients [11]. The gene discussed is PMP22; the disease is Charcot-Marie-Tooth disease type 1A.